Next Article in Journal
Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial
Previous Article in Journal
Consumption Trends of Antifungal and Antiprotozoal Agents for Human Systemic Use in Kazakhstan from 2017 to 2023
 
 
Review

Article Versions Notes

Antibiotics 2024, 13(9), 856; https://doi.org/10.3390/antibiotics13090856
Action Date Notes Link
article xml file uploaded 6 September 2024 14:42 CEST Original file -
article xml uploaded. 6 September 2024 14:42 CEST Update https://www.mdpi.com/2079-6382/13/9/856/xml
article pdf uploaded. 6 September 2024 14:42 CEST Version of Record https://www.mdpi.com/2079-6382/13/9/856/pdf
article supplementary file uploaded. 6 September 2024 14:42 CEST - https://www.mdpi.com/2079-6382/13/9/856#supplementary
article html file updated 6 September 2024 14:44 CEST Original file https://www.mdpi.com/2079-6382/13/9/856/html
Back to TopTop